Gordon H Baltuch, MD | |
235 S 8th St, Philadelphia, PA 19106-3519 | |
(215) 829-6700 | |
(215) 829-6645 |
Full Name | Gordon H Baltuch |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 38 Years |
Location | 235 S 8th St, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932144094 | NPI | - | NPPES |
0015989750001 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD058514L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
New York-presbyterian Hospital | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Columbia Doctors Of New Jersey, P. C. | 3375674138 | 41 |
Trustees Of Columbia University In The City Of New York | 8527972546 | 1895 |
News Archive
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
When head and neck tumors - from sinus tumors to acoustic neuromas attached to the hearing and balance nerve at the base of the skull - are located in close proximity to such sensitive areas such as the brain and eyes, they are particularly dangerous due to possible brain injury, visionary risk or hearing loss.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.
› Verified 9 days ago
Entity Name | Clinical Health Care Associates Of New Jersey Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508019241 PECOS PAC ID: 0749180198 Enrollment ID: O20050725000214 |
News Archive
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
When head and neck tumors - from sinus tumors to acoustic neuromas attached to the hearing and balance nerve at the base of the skull - are located in close proximity to such sensitive areas such as the brain and eyes, they are particularly dangerous due to possible brain injury, visionary risk or hearing loss.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.
› Verified 9 days ago
Entity Name | Columbia Doctors Of New Jersey, P. C. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144459991 PECOS PAC ID: 3375674138 Enrollment ID: O20100623000754 |
News Archive
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
When head and neck tumors - from sinus tumors to acoustic neuromas attached to the hearing and balance nerve at the base of the skull - are located in close proximity to such sensitive areas such as the brain and eyes, they are particularly dangerous due to possible brain injury, visionary risk or hearing loss.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Gordon H Baltuch, MD 235 S 8th St, Philadelphia, PA 19106-3519 Ph: (215) 829-6700 | Gordon H Baltuch, MD 235 S 8th St, Philadelphia, PA 19106-3519 Ph: (215) 829-6700 |
News Archive
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
When head and neck tumors - from sinus tumors to acoustic neuromas attached to the hearing and balance nerve at the base of the skull - are located in close proximity to such sensitive areas such as the brain and eyes, they are particularly dangerous due to possible brain injury, visionary risk or hearing loss.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.
› Verified 9 days ago
Xun Li, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-316-5151 | |
Dr. Ahmet Fatih Atik, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Cotton St, Philadelphia, PA 19127 Phone: 215-892-7600 | |
Dr. Srinivasa Prasad Venkata Kanuparthi, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 | |
John Y Lee, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 3 Silverstein Bldg, Philadelphia, PA 19104 Phone: 215-662-3487 | |
Dr. Nduka Mgbechinyere Amankulor, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Civic Center Blvd, 2nd Flr South Pavilion, Philadelphia, PA 19104 Phone: 215-662-3487 Fax: 215-349-5534 | |
Kareem Amir Zaghloul, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104 Phone: 215-662-3957 | |
Dr. Bong-soo Kim, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3509 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 |